Revenue | {{ Info.Revenue | formatUSD }} |
Headquarters | {{ Info.Headquarters }} |
Registration status | Registration Changed to AVIDITY PARTNERS MANAGEMENT LP |
Exempt Reporting Adviser
2B(3)- PF>150mn
act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more |
|
Private Fund GAV* | 0 |
SMA’s | No |
Private Funds | 0 |
Contact Info | 214 xxxxxxx |
Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
---|---|---|---|---|---|
Stck Ticker101137107 | Stock NameBOSTON SCIENTIFIC CORP | $ Position$33,895,680 | % Position6.00% | $ Change-26.00% | # Change-35.00% |
Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$31,217,162 | % Position6.00% | $ Change-50.00% | # Change-40.00% |
Stck Ticker156944100 | Stock NameCG ONCOLOGY INC | $ Position$24,023,270 | % Position5.00% | $ Change-24.00% | # Change-11.00% |
Stck Ticker91324P102 | Stock NameUNITEDHEALTH GROUP INC | $ Position$26,449,375 | % Position5.00% | $ Change-13.00% | # Change-16.00% |
Stck Ticker444859102 | Stock NameHUMANA INC | $ Position$21,432,600 | % Position4.00% | $ Change-5.00% | # Change-9.00% |
Stck Ticker444859102 | Stock NameHUMANA INC (CALL) | $ Position$21,168,000 | % Position4.00% | $ Change | # Change |
Stck Ticker377322102 | Stock NameGLAUKOS CORP | $ Position$13,188,280 | % Position3.00% | $ Change-48.00% | # Change-21.00% |
Stck Ticker30063P105 | Stock NameEXACT SCIENCES CORP | $ Position$15,281,370 | % Position3.00% | $ Change-55.00% | # Change-41.00% |
Stck Ticker07373V105 | Stock NameBEAM THERAPEUTICS INC | $ Position$13,856,867 | % Position3.00% | $ Change | # Change |
Stck Ticker632307104 | Stock NameNATERA INC | $ Position$16,856,072 | % Position3.00% | $ Change-52.00% | # Change-47.00% |